VIR
#2130
Vir Biotechnology, Inc. - Common Stock
9.7 2 USD
-0.02%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.41%
Variación mensual
+11.34%
Variación en los últimos 6 meses
+42.73%
Cambio anual
+62.54%
Cierres anteriores
9.9 6
Open
9.7 2
Mínimo
9.7 2
High
9.7 2
Volumen
117
Financials
- Market Capitalization 1.64 B
- Employee 367
- Founded 2016
- CEO Marianne De Backer
- Website www.vir.bio
- Headquarter Delaware, United States
- FIGI BBG00H2QQ8T5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.86
Relación precio/flujo de caja
18.95
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2124 |  IMCR Immunocore Holdings plc - American Depositary Shares | 32.49 USD | +1.69% | +1.15% | +12.19% | -2.96% | 1.65 B USD | ||
| 2127 |  MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 6.36 USD | +4.43% | +7.80% | +26.69% | +139.10% | 1.64 B USD | ||
| 2131 |  INVA Innoviva, Inc. - Common Stock | 22.21 USD | -0.13% | +0.45% | -2.24% | +24.64% | 1.64 B USD | ||
| 2146 |  ABSI Absci Corporation - Common Stock | 10.21 USD | -3.68% | -14.06% | +38.72% | +283.83% | 1.59 B USD |